BUY MBP CERITINIB SPEXIB 150MG CAP 10’S CAP BEST PRICE ONLINE IN NIGERIA LAGOS ABUJA KANO AND PORTHARCOURT AT MYBIGPHARMACY.COM

Description

Dear friend, this medication requires a prescription or medical license before it can be delivered to you. kindly ensure that you provide us with a reliable contact information at checkout, mybigpharmacy team will be in touch with you to obtain required document before your order is confirmed thank you for trusting mybig pharmacy with your health. Ceritinib is an anticancer medicine used mainly to treat non-small cell lung cancer (NSCLC) that is ALK-positive. This means it is used in patients whose cancer cells have a specific genetic change called an ALK (anaplastic lymphoma kinase) rearrangement. Ceritinib works by targeting this abnormal protein and slowing or stopping the growth of cancer cells.

Ceritinib belongs to a group of medicines called tyrosine kinase inhibitors. These medicines block specific signals that cancer cells use to grow and survive. By blocking the ALK protein, ceritinib helps stop cancer cells from multiplying and spreading to other parts of the body.

Ceritinib is taken by mouth, usually once daily, and should be taken with food, as food helps improve absorption and reduces stomach-related side effects. The tablets should be swallowed whole and not crushed or chewed. It is very important to take ceritinib at the same time every day to maintain steady levels of the medicine in the body.

Common side effects include nausea, vomiting, diarrhoea, abdominal pain, loss of appetite, fatigue, and weight loss. These effects are often more noticeable at the beginning of treatment and may improve over time. Taking the medication with food and using supportive medicines can help manage these symptoms.

Ceritinib can also affect the liver, so regular blood tests are required to monitor liver function. Symptoms such as yellowing of the eyes or skin, dark urine, severe fatigue, or upper abdominal pain should be reported immediately. Liver problems are usually reversible when detected early and managed properly.

This medicine may affect the heart rhythm, causing a condition known as QT prolongation. Because of this, doctors may perform ECGs and monitor electrolyte levels during treatment. Symptoms such as dizziness, fainting, or irregular heartbeat should be reported urgently.

Ceritinib can also raise blood sugar levels, even in people without diabetes. Blood glucose monitoring may be required, especially in patients with diabetes or those at risk. Symptoms of high blood sugar include increased thirst, frequent urination, fatigue, and blurred vision.

Some patients may experience inflammation of the lungs, known as pneumonitis. This can cause shortness of breath, cough, or chest discomfort and requires immediate medical attention.

Ceritinib can interact with many other medicines, including antifungal drugs, antibiotics, seizure medications, and herbal supplements such as St John?s wort. Grapefruit and grapefruit juice should be avoided, as they can increase the level of ceritinib in the blood and raise the risk of side effects.

Ceritinib can harm an unborn baby and should not be used during pregnancy. Effective contraception is required during treatment and for some time after stopping the medication. Breastfeeding is not recommended while taking ceritinib.

Patients should not stop ceritinib suddenly without medical advice, even if they feel well. Regular follow-up visits, blood tests, and scans are essential to monitor response and detect side effects early.

When taken correctly and monitored closely, ceritinib can significantly slow disease progression, reduce tumour burden, and improve quality of life for people with ALK-positive lung cancer.